Jh. Lin et Fj. Castora, RESPONSE OF PURIFIED MITOCHONDRIAL-DNA TOPOISOMERASE-I FROM BOVINE LIVER TO CAMPTOTHECIN AND M-AMSA, Archives of biochemistry and biophysics, 324(2), 1995, pp. 293-299
The type I DNA topoisomerase isolated from bovine liver mitochondria i
s demonstrated here to be inhibited by camptothecin, a plant alkaloid
previously shown to target the nuclear type I topoisomerase in mammali
an cells. The antitumor drug reduces the ability of the mitochondrial
enzyme to relax positive as well as negative supercoils although the i
nhibition of the former process requires more than 60-fold more drug t
han the latter process. A similar response is seen with the nuclear to
poisomerase I. Camptothecin also stimulates the mitochondrial topoisom
erase-induced cleavage of pUC19 at numerous, discrete sites. The antit
umor drug 4'-(9-acridinylamino)-methanesulfon-m-anisidide, which has b
een shown to target the nuclear topoisomerase II, inhibited the mitoch
ondrial type I topoisomerase relaxation activity, but this effect was
found to be the result of the drug intercalating into the negatively s
upercoiled DNA rather than from a specific interaction with the mitoch
ondrial enzyme. VM-26, a nonintercalating topoisomerase II poison, sho
wed no inhibitory effect up to a concentration of 50 mu M. (C) 1996 Ac
ademic Press, Inc.